Headquartered in Dublin, Medergie focuses on optimizing development and clinical use of neuromodulation technologies.
Medergie is involved in all clinical, technical and commercial aspects of neuromodulation.
Our teams of international scientists and engineers lead the research, design, development and manufacturing of our cutting-edge technologies.
Our international network of physicians clinically evaluates and refines our novel interventions to ensure that we positively enhance treatment outcomes.
Our regulatory and commercial experts ensure that we can bring our revolutionary technologies to patients in all regions of the globe.
Our development approach provides:
- Versatile Neuromodulation Device Platform
- A Creative Sponsoring Approach
- International Collaborative Forums
